Piper Sandler & Co’s Cabaletta Bio CABA Stock Holding History

Piper Sandler & Co’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-145,000	Closed	-$154K	–	40
2022 Q2	$154K	Buy	+145,000	New	+$205K	0.14%	33

Other funds holding CABA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Piper Sandler & Co's CABA Position: Q3 2022 in Review

Piper Sandler & Co sold out of Cabaletta Bio (CABA) in Q3 2022, closing a stake of 145,000 shares — an estimated $154K sold.

Piper Sandler & Co first reported a position in CABA in Q2 2022 and held it in 1 quarter. The position peaked at $154K in Q2 2022. 54 funds tracked by Wall St. Rank hold CABA as of Q3 2022.

Piper Sandler & Co reported no remaining Cabaletta Bio position as of Q3 2022 after selling out during the quarter.
Piper Sandler & Co sold 145,000 Cabaletta Bio shares in Q3 2022, an estimated $154K.
Piper Sandler & Co first reported a position in Cabaletta Bio in Q2 2022 and held it in 1 quarter.
Piper Sandler & Co's Cabaletta Bio position peaked at $154K in Q2 2022.
54 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2022.

Based on Piper Sandler & Co's 13F filing for Q3 2022, filed 14 Nov 2022.